Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 10, 2004, Pages 2661-2664

  Cheon, Hyae Gyeong ^a   Lee, Chul Min ^b   Kim, Beom Tae ^b   Hwang, Ki Jun ^b  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; QUINOXALINE DERIVATIVE;

ARTICLE; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; HIGH THROUGHPUT SCREENING; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIGENS, CD26; AUTOMATION; PROTEASE INHIBITORS; PROTEIN ARRAY ANALYSIS; QUINOXALINES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1942502390     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.02.065     Document Type: Article

References (18)

1. Holst J.J., Deacon C.F. Diabetes. 47:1998;1663.
2. Ahren B. BioEssays. 20:1998;642.
3. Willms B., Werner J., Holst J.J., Orskov C., Creutzfeldt W., Nauck M.A. J. Clin. Endocrinol. Metab. 81:1996;327.
4. Deacon C.F., Prodal L., Klarskov L., Olesen M., Holst J.J. Am. J. Physiol. 271:1996;E458.
5. Mentlein R., Gallwitz B., Schmidt W.E. Eur. J. Biochem. 214:1993;829.
6. Schon E., Mansfold H.W., Demuth H.U., Barth A., Ansorge S. Biomed. Biochim. Acta. 44:1985;K9.
7. Gruher M., Scholz W., Flad H.D. Cell Immunol. 113:1988;423.
8. Yaron A., Naider F. Crit. Rev. Biochem. Mol. Biol. 28:1993;31.
9. Vilsboll T., Krarup T., Deacon C.F. Diabetes. 50:2001;609.
10. Ahren B., Simmonsson E., Larsson H., Landin-Olsson M., Torheirsson H., Jansson P.A., Sandqvist M., Bavenholm P., Efendic S., Eviksson J.W., Dickinson S., Holmes D. Diabetes Care. 25:2002;869.
11. Villhauer E.B., Brinkman J.A., Naderi G.B., Dunning B.E., Mangold B.L., Mone M.D., Russell M.E., Weldon S.C., Hughes T.E. J. Med. Chem. 45:2002;2362.
12. Villhauer E.B., Brinkman J.A., Naderi G.B., Burkey B.F., Dunning B.E., Prasad K., Mangold B.L., Russell M.E., Hughes T.E. J. Med. Chem. 46:2003;2774.
13. Cai S.X., Kher S.M., Zhou Z., Espitia S.A., Tran M., Hawkinson J.E., Woodward R.M., Weber E., Keana F.W. J. Med. Chem. 40:1997;730.
14. Wallace R.G. Org. Prep. Proc. Int. 14:1982;269.
15. 2), 6.90 (d, 1H, -9H), 7.76 (d, 1H, -8H), 8.13 (m, 1H, -6H), 12.06 (br, 1H, -NH-).
16. Paquette L.A. Reagents for Organic Synthesis. 2:1995;1007-1009 John Wiley and Sons.
17. Balkan B., Kwasnik L., Milserendino R., Holst J.J. Diabetologia. 42:1999;1324.
18. 50 values (μm): entry 1, 22.1; entry 2, 18.7; entry 3, 25.8; entry 4, 18.4; entry 5, 12.7.